Erythromycin for four or seven days against Chlamydia trachomatis.
D002690:Chlamydia Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004917:Erythromycin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male
D004917:Erythromycin